Fig. 1. Effect of -tocopherol (-toc) supplementation on -tocopherol (A) and cholesterol (B) content in plasma lipoprotein fractions separated by FPLC in controls and CHD-patients.
Fig. 3. Increase of molar -tocopherol content in VLDL (A), LDL (B), and HDL (C) under -tocopherol supplementation. Data are expressed as mean ± SD, significant differences are marked with * (p < 0.05) and ** (p < 0.01).